Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms.
We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services.
Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial manufacturing and packaging activities.
Our value proposal includes tailored services to clients’ requirements supporting them up to market introduction.
Skyepharma is part of the Vectura Group of Companies (LSE: VEC), an industry-leading device and formulation company specialized in airways disease.
Please visit Vectura web site : www.vectura.com
Why does Skyepharma represent a strategic partner for its clients ?
Today’s pharmaceutical obligations in terms of quality and capabilities are decisive for industry players. Skyepharma answers to these necessities by coming up with a wide range of services in line with market’s requirements. Our premium positioning on the pharmaceutical market place comes from our development and production processes expertise.